Search Within

Michael S Baum

  1. "Body Imaging Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Body Imaging Service (9)
  2. Cardiology (9)
  3. Department of Medicine (9)
  4. Division of Subspecialty Medicine (9)
  5. Genitourinary Oncology Service (9)
  6. Radiology, Department of (9)

More Groups

People
  1. Robert Motzer (9)
  2. Michelle Ginsberg (8)
  3. Darren Feldman (6)
  4. Patricia Fischer (5)
  5. Ellen Ronnen (4)
  6. Sujata Patil (4)

More People

Years
  1. 2012 (2)
  2. 2010 (1)
  3. 2009 (1)
  4. 2008 (1)
  5. 2007 (3)
  6. 2006 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. American Journal of Hematology/Oncology (2)
  3. American Journal of Clinical Oncology (1)
  4. Cancer (1)
  5. Investigational New Drugs (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Haymarket Media Inc. (2)
  3. Lippincott Williams & Wilkins (1)
  4. Springer (1)
  5. Wiley Blackwell (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Voss, M. H.; Ginsberg, M. S.; Baum, M. S.; Brocks, D. R.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Motzer, R. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Kroog, G.; Tickoo, S. K.; Jia, X.; Georges, M.; Patil, S.; Baum, M. S.; Reuter, V. E.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hudes, G. R.; Ginsberg, M. S.; Baum, M. S.; Harmon, C. S.; Kim, S. T.; Chen, I.; Redman, B. G.
    American Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Feldman, D. R.; Baum, M. S.; Ginsberg, M. S.; Hassoun, H.; Flombaum, C. D.; Velasco, S.; Fischer, P.; Ronnen, E.; Ishill, N.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Feldman, D. R.; Ginsberg, M. S.; Baum, M.; Flombaum, C.; Hassoun, H.; Velasco, S.; Fischer, P.; Ishill, N. M.; Ronnen, E. A.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Feldman, D. R.; Kondagunta, G. V.; Ronnen, E. A.; Fischer, P.; Chang, R.; Baum, M.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Superior efficacy of sunitinib compared with interferon as first-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Schwartz, L. H.; Baum, M. S.; Motzer, R. J.
    American Journal of Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • Efficacy and safety of sunitinib as second-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Feldman, D. R.; Baum, M. S.; Ginsberg, M.
    American Journal of Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • A phase I study of sunitinib malate (SU11248) in combination with gefitinib in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Ronnen, E. A.; Kondagunta, G. V.; Lau, C.; Fischer, P.; Ginsberg, M. S.; Baum, M.; Kim, S. T.; Chen, I.; Baum, C. M.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save